Search

everythinglearnresearchcommunity

for

Search:↓

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Transplant patients often get skin problems, with treatments varying by condition.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Metformin may help treat neuroendocrine tumors.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Skin reactions from cancer treatments might predict how well the treatments work.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.